Who owns the OMNIDAB trademark?

The OMNIDAB trademark is owned by Ligand Pharmaceuticals Incorporated.

What is the serial number for OMNIDAB?

The USPTO serial number for OMNIDAB is 87880219.

What is the registration number for OMNIDAB?

OMNIDAB is registered under USPTO registration number 0.

OMN

USPTO Trademark Record

ABANDONED

OMNIDAB

Q: What class is the OMNIDAB trademark registered in?

The OMNIDAB trademark is registered in Class 001 (Chemicals for industrial, scientific & agricultural use), Class 042 (Scientific, technology & SaaS services).

SN 87880219·Reg 0·Filed Apr 17, 2018

Owner Ligand Pharmaceuticals Incorporated

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hides; adhesives for use in industry; compost, manures, fertilizers; biological preparations for use in industry and science.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

OMNIDAB (Serial No. 87880219), Registration No. 0, is a abandoned US trademark filed on Apr 17, 2018 by Ligand Pharmaceuticals Incorporated. This trademark covers Class 001 (Chemicals for industrial, scientific & agricultural use), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

OMNIDAB (Reg. #0) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 001 (Chemicals for industrial, scientific & agricultural use) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocesse.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 17, 2018

SERIAL

87880219

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Ligand Pharmaceuticals Incorporated

Entity

Corporation

State

Address

3911 Sorrento Valley Boulevard, Ste. 110, San Diego, CA, 92121

Country

Attorney

NameLisa M. Martens

Law firm

Lisa M. Martens SHEPPARD MULLIN RICHTER & HAMPTON LLP

Docket

47XX-271899

Address

12275 EL CAMINO REAL, SUITE 200, SAN DIEGO, CA 92130-2006, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateApr 17, 2018

Serial Number87880219

Registration No.0

Registration DateDec 31, 1969

Status DateOct 11, 2021

Published for OppositionJul 10, 2018

Mark TypeStandard characters

Attorney Docket47XX-271899

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 001Chemicals for industrial, scientific & agricultural use

US codes: 001, 005, 006, 010, 026, 046

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

32 events

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 12, 2021

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Oct 11, 2021

ABANDONMENT - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 23, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 22, 2021

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Jun 22, 2021

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Feb 24, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Feb 24, 2021

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 29, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 FILED

Aug 27, 2020

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Aug 27, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 GRANTED

Aug 27, 2020

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 28, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Jan 27, 2020

SOU EXTENSION 3 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 21, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Jan 21, 2020

SOU EXTENSION 3 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 28, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Aug 27, 2019

SOU EXTENSION 2 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 27, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Aug 22, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Aug 22, 2019

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 14, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Feb 12, 2019

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 12, 2019

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Feb 12, 2019

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 04, 2018

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 10, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jul 10, 2018

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 20, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 31, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

May 30, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 25, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 20, 2018

NEW APPLICATION ENTERED

Other Marks in Class 001 — Chemicals for industrial, scientific & agricultural use

Recently filed and registered marks in the same international class.

OMN

OMNIDAB

98120280

OMNIAB, INC.

REGISTERED

OMN

OMNIDAB

97005507

Crystal Bioscience, Inc.

REGISTERED

OMNIDAB

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Ligand Pharmaceuticals Incorporated

Other Marks in Class 001 — Chemicals for industrial, scientific & agricultural use

Other Marks by Lisa M. Martens

Resources

Company